The fen-phen finale: a study of weight loss and valvular heart disease (Q42540665)

2 November 2017

title

The fen-phen finale: a study of weight loss and valvular heart disease (English)

1 reference

2 November 2017

Wadden TA

1

1 reference

2 November 2017

Berkowitz RI

2

1 reference

2 November 2017

Silvestry F

3

1 reference

2 November 2017

Vogt RA

4

1 reference

2 November 2017

St John Sutton MG

5

1 reference

2 November 2017

Stunkard AJ

6

1 reference

2 November 2017

Foster GD

7

1 reference

2 November 2017

Aber JL

8

1 reference

2 November 2017

publication date

1 July 1998

1 reference

2 November 2017

1 reference

2 November 2017

volume

6

1 reference

2 November 2017

issue

4

1 reference

2 November 2017

page(s)

278-284

1 reference

Valvular heart disease associated with fenfluramine-phentermine

2 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1002%2FJ.1550-8528.1998.TB00350.X

Losing weight--an ill-fated New Year's resolution

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1550-8528.1998.TB00350.X

Lifestyle modification in the pharmacologic treatment of obesity: a pilot investigation of a potential primary care approach

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1550-8528.1998.TB00350.X

Use and abuse of appetite-suppressant drugs in the treatment of obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1550-8528.1998.TB00350.X

Continuous wave Doppler determination of right ventricular pressure: a simultaneous Doppler-catheterization study in 127 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1550-8528.1998.TB00350.X

Noninvasive estimation of right ventricular systolic pressure by Doppler ultrasound in patients with tricuspid regurgitation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1550-8528.1998.TB00350.X

Appetite-suppressant drugs and the risk of primary pulmonary hypertension. International Primary Pulmonary Hypertension Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1550-8528.1998.TB00350.X

Combined drug treatment of obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1550-8528.1998.TB00350.X

Long-term weight control study. III (weeks 104 to 156). An open-label study of dose adjustment of fenfluramine and phentermine

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1550-8528.1998.TB00350.X

Treatment of obesity by moderate and severe caloric restriction. Results of clinical research trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1550-8528.1998.TB00350.X

Effect of degree of weight loss on health benefits

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1550-8528.1998.TB00350.X

Year-long weight loss treatment for obese patients with type II diabetes: does including an intermittent very-low-calorie diet improve outcome?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1550-8528.1998.TB00350.X

10.1002/J.1550-8528.1998.TB00350.X

21 January 2018

Identifiers

DOI

1 reference

2 November 2017

1 reference